Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BG-570 by SL Bigen for Tuberculosis: Likelihood of Approval
BG-570 is under clinical development by SL Bigen and currently in Phase I for Tuberculosis. According to GlobalData, Phase I...